CytoSorbents Corporation Nasdaq: CTSO Q1 2026 Earnings Conference Call May 13, 2026 Conference Call Participants Phillip Chan, MD, PhD Chief Executive Officer Peter J. Mariani, CPA Chief Financial Officer Efthymios Deliargyris, MD Chief Medical Officer 2 Safe Harbor Statement Statements in this presentation include forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, bu ...